尽管前景乐观,但Aveanna Healthcare在 2025 年第四季度的业绩强:收入增长 27.4%,调整后 EBITDA 上升 54%. Aveanna Healthcare posted strong Q4 2025 results with revenue up 27.4% and adjusted EBITDA up 54%, but shares dropped 11% despite the positive outlook.

艾维安纳医疗报告了强的2025年第四季度业绩,收入增长27.4%,达到6.62亿美元,调整后EBITDA增加54%,至8.5亿美元.这是由于所有细分市场的增长,更高的护理量,提高费率和运营效率所推动的. Aveanna Healthcare reported strong Q4 2025 results, with revenue rising 27.4% to $662 million and adjusted EBITDA up 54% to $85 million, driven by growth across all segments, higher care volumes, improved rates, and operational efficiencies. 该公司提供了1240万个护理小时,增长17.9%,并预计2026年的收入为254亿美元至256亿美元,调整后的EBITDA为3.18亿美元到3.222亿美元.不包括17555百万美元的待定收购. The company delivered 12.4 million care hours, up 17.9%, and projected 2026 revenue of $2.54 billion to $2.56 billion and adjusted EBITDA of $318 million to $322 million, excluding a pending $175.5 million acquisition. 尽管市场表现良好,但股价下跌11%,至6.15美元,没有明确的解释. Despite the positive performance, shares fell 11% to $6.15, with no clear explanation provided for the market reaction.